This Article Full Text (PDF) All Versions of this Article: 1073858409333069v1 15/4/324    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Gibson, C. L Articles by Rathbone, J. PubMed PubMed Citation Articles by Gibson, C. L Articles by Rathbone, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PROGESTERONE Medline Plus Health Information Stroke Social Bookmarking                         What's this?

Is Progesterone a Candidate Neuroprotective Factor for Treatment following Ischemic Stroke?

School of Psychology, University of Leicester, Leicester, United Kingdom, cg95{at}le.ac.uk

Ben Coomber

School of Psychology, University of Leicester, Leicester, United Kingdom

James Rathbone

School of Psychology, University of Leicester, Leicester, United Kingdom

Gender differences in stroke outcome have implicated steroid hormones as potential neuroprotective candidates. However, no clinical trials examining hormone replacement therapy on outcome following ischemic stroke have investigated the effect of progesterone-only treatment. In this review the authors examine the experimental evidence for the neuroprotective potential of progesterone and give an insight into potential mechanisms of action following ischemic stroke. To date, 17 experimental studies have investigated the neuroprotective potential of progesterone for ischemic stroke in terms of ability to both reduce cell loss and increase functional outcome. Of these 17 published studies the majority reported a beneficial effect with three studies reporting a nil effect and only one study reporting a negative effect. However, there are important issues that the authors address in this review in terms of the methodological quality of studies in relation to the STAIR recommendations. In terms of the proposed mechanisms of progesterone neuroprotection we show that progesterone is versatile and acts at multiple targets to facilitate neuronal survival and minimize cell damage and loss. A large amount of experimental evidence indicates that progesterone is a neuroprotective candidate for ischemic stroke; however, to progress to clinical trial a number of key experimental studies remain outstanding.

Key Words: progesterone • focal ischemia • neuroprotection • steroids • stroke

This version was published on August 1, 2009

The Neuroscientist, Vol. 15, No. 4, 324-332 (2009)
DOI: 10.1177/1073858409333069


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?